Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong-Yan Peng

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
World Journal of Oncology|January 26, 2024
Inhibiting the m<sup>6</sup>A Reader IGF2BP3 Suppresses Ovarian Cancer Cell Growth via Regulating PLAGL2 mRNA StabilizationTian Tian Dai, Yi Ze Li, Hui Ting Hu, et al.
Clinical and Experimental Pharmacology & Physiology|December 18, 2013
Advanced glycation end-products impair Na⁺/K⁺-ATPase activity in diabetic cardiomyopathy: role of the adenosine monophosphate-activated protein kinase/sirtuin 1 pathwayQiong Yuan, Qian-Yi Zhou, Du Liu, et al.
Acta Pharmacologica Sinica|July 5, 2023
mTORC2 acts as a gatekeeper for mTORC1 deficiency-mediated impairments in ILC3 developmentYa-Fei Deng, Shu-Ting Wu, Hong-Yan Peng, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
World Journal of Oncology|January 26, 2024
Inhibiting the m<sup>6</sup>A Reader IGF2BP3 Suppresses Ovarian Cancer Cell Growth via Regulating PLAGL2 mRNA StabilizationTian Tian Dai, Yi Ze Li, Hui Ting Hu, et al.
Clinical and Experimental Pharmacology & Physiology|December 18, 2013
Advanced glycation end-products impair Na⁺/K⁺-ATPase activity in diabetic cardiomyopathy: role of the adenosine monophosphate-activated protein kinase/sirtuin 1 pathwayQiong Yuan, Qian-Yi Zhou, Du Liu, et al.
Acta Pharmacologica Sinica|July 5, 2023
mTORC2 acts as a gatekeeper for mTORC1 deficiency-mediated impairments in ILC3 developmentYa-Fei Deng, Shu-Ting Wu, Hong-Yan Peng, et al.
Pageof 2